CARVIN MEDICINES IS A
About Carvin Medicines
We are on the leading edge of developing treatment protocols for chronic neurogenic disease with novel MEDICINES
In Exclusive Partnership with 37-year old Swiss Pharma company, Alpex Pharma S.A., we are developing FDA and EMA approved drugs and treatment protocols, and leveraging manufacturing expertise by to streamlining formulation, stability, regulatory requirements, and drug registration. Our formulations are designed to mitigate common side effects and improve the drug efficacy by pairing APIs with our patented delivery technologies.
Targeting Unique Diseases
With unmet patient needs that are typically treated by Opiates, SSRIs, SDRIs, and SNRIs.
Intellectual Property based on proprietary formulations and delivery technologies for optimum efficacy and success.
In full control of the drug development life cycle with immediate capacity to scale and deploy for Clinical Trials and Commercialization.
Our treatments have promise to set the new standard of care for chronic neurogenic disease with poor treatment options and better serve patient needs.
Developing medicines and regiments with existing psychedelic compounds for chronic administration.
Patented technologies for optimum drug delivery resulting in faster onset, safety and tolerability.
Mitigates Side Effects
Proprietary regimen of micro and low dose formulations eliminate perceptual any physical side effects.
Targeted modality of drug administration that is designed to reach the therapeutic objective for treatment of neurogenic disease.
Our platform, based on 37 years of internal drug development expertise, is applicable to proprietary medicines as well as contracting and/or licensing to third parties for any compound or psychedelic API.
Our flexible partnership structures for R&D, Formulation and Development:
Carvin initiates project, and self funds drug development, and fully owns IP. Alpex then licenses to partners for marketing, sales and distribution in global markets.
Co-Develop in Partnership
Partners initiate project with concept and desired API. Alpex develops and commercializes the product. Partner handles marketing, sales & distribution in target markets.
Commercial Contract Partner
Carvin provides full contract development and manufacturing service for every aspect of drug development and manufacturing in a client-fee commercial relationship.
OUR GLOBAL PRESENCE
Mind and Matter
& Novel Medicines